PIKFYVE KINASE INHIBITOR

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250042914A1
SERIAL NO

18696960

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to a thieno[3,2-d]pyrimidine derivative compound which is useful as a PIKfyve kinase inhibitor, a pharmaceutically acceptable salt thereof, a preparation method thereof, and an intermediate thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANMI PHARM CO LTD214 MUHA-RO PALTAN-MYEON HWASEONG-SI GYEONGGI-DO 18536 18536

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chung, Shin Hyuck Hwaseong-si, Gyeonggi-do, KR 1 0
Jang, Sun Young Hwaseong-si, Gyeonggi-do, KR 8 36
Jun, Seung Ah Hwaseong-si, Gyeonggi-do, KR 5 26
Kim, Ye Lim Hwaseong-si, Gyeonggi-do, KR 2 0
Suh, Kwee Hyun Hwaseong-si, Gyeonggi-do, KR 43 97

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation